Inventor
AGGARWAL BHARAT B
US24 patents
⚠️ This page may combine multiple inventors who share the name “AGGARWAL BHARAT B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RES DEV FOUNDATION
15 patentsUS6475986B1Nov 5, 2002
Uses of THANK, a TNF homologue that activates apoptosis
RES DEV FOUNDATION58 citations96
US5891924AApr 6, 1999
Curcumin (diferuloylmethane) inhibition of NFκB activation
RES DEV FOUNDATION83 citations96
US5650316AJul 22, 1997
Uses of triplex forming oligonucleotides for the treatment of human diseases
RES DEV FOUNDATION81 citations96
US7241576B2Jul 10, 2007
Uses of THANK, a TNF homologue that activates apoptosis
RES DEV FOUNDATION30 citations92
US5658949AAug 19, 1997
Inhibition of tumor necrosis factor by retinoic acid
RES DEV FOUNDATION18 citations92
US5856161AJan 5, 1999
Tumor necrosis factor receptor-I-associated protein kinase and methods for its use
RES DEV FOUNDATION21 citations90
US5457129AOct 10, 1995
Inhibition of nitric oxide production by retinoic acid
RES DEV FOUNDATION6 citations73
US5981583ANov 9, 1999
Inhibition of nuclear transcription factor NF-κB by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
RES DEV FOUNDATION15 citations72
US5837817ANov 17, 1998
Tumor necrosis factor receptor-II-associated protein kinase and methods for its use
RES DEV FOUNDATION9 citations71
US7462646B2Dec 9, 2008
Osteoclastogenesis inhibitors and uses thereof
RES DEV FOUNDATION3 citations63
US6605278B1Aug 12, 2003
Uses of trank, a novel secretory cytokine
RES DEV FOUNDATION4 citations63
US7368430B2May 6, 2008
Selective inhibitors of nuclear factor-κB activation and uses thereof
RES DEV FOUNDATION4 citations59
US5977058ANov 2, 1999
Antiproliferative protein from Bacillus thuringiensis var. thuringiensis
RES DEV FOUNDATION5 citations57
US5993798ANov 30, 1999
Oncoinhibin and methods of pharmaceutical use
RES DEV FOUNDATION0 citations52
US5241051AAug 31, 1993
Oncoinhibin
RES DEV FOUNDATION1 citations52
GENENTECH INC
8 patentsUS5795967AAug 18, 1998
Tumor necrosis factor antagonists and their use
GENENTECH INC350 citations97
US5672347ASep 30, 1997
Tumor necrosis factor antagonists and their use
GENENTECH INC280 citations97
US4650674AMar 17, 1987
Synergistic cytotoxic composition
GENENTECH INC105 citations95
US5824509AOct 20, 1998
Recombinant lymphotoxin cDNA and variants
GENENTECH INC19 citations91
US4920196AApr 24, 1990
Human lymphotoxin
GENENTECH INC22 citations82
US5683688ANov 4, 1997
Unglycosylated recombinant human lymphotoxin polypeptides and compositions
GENENTECH INC7 citations72
US6177543B1Jan 23, 2001
Recombinant lymphotoxin
GENENTECH INC2 citations61
US6686455B1Feb 3, 2004
Tumor necrosis factor
GENENTECH INC1 citations52